| Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study G Wu, P Yang, Y Xie, HC Woodruff, X Rao, J Guiot, AN Frix, R Louis, ... European Respiratory Journal 56 (2), 2020 | 300 | 2020 |
| A review in radiomics: making personalized medicine a reality via routine imaging J Guiot, A Vaidyanathan, L Deprez, F Zerka, D Danthine, AN Frix, ... Medicinal research reviews 42 (1), 426-440, 2022 | 213 | 2022 |
| Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection D Calmes, S Graff, N Maes, AN Frix, M Thys, O Bonhomme, J Berg, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (1), 160-169, 2021 | 90 | 2021 |
| Radiomics in lung diseases imaging: state-of-the-art for clinicians AN Frix, F Cousin, T Refaee, F Bottari, A Vaidyanathan, C Desir, W Vos, ... Journal of Personalized Medicine 11 (7), 602, 2021 | 72 | 2021 |
| Positive effects of vitamin D supplementation in patients hospitalized for COVID-19: a randomized, double-blind, placebo-controlled trial S De Niet, M Trémège, M Coffiner, AF Rousseau, D Calmes, AN Frix, ... Nutrients 14 (15), 3048, 2022 | 64 | 2022 |
| Development and validation of an automated radiomic CT signature for detecting COVID-19 J Guiot, A Vaidyanathan, L Deprez, F Zerka, D Danthine, AN Frix, M Thys, ... Diagnostics 11 (1), 41, 2020 | 60 | 2020 |
| Could KL-6 levels in COVID-19 help to predict lung disease? AN Frix, L Schoneveld, A Ladang, M Henket, B Duysinx, F Vaillant, ... Respiratory research 21, 1-4, 2020 | 42 | 2020 |
| Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study A Chatterjee, G Wu, S Primakov, C Oberije, H Woodruff, P Kubben, ... PloS one 16 (4), e0249920, 2021 | 28 | 2021 |
| YKL-40 as a new promising prognostic marker of severity in COVID infection L Schoneveld, A Ladang, M Henket, AN Frix, E Cavalier, J Guiot Critical Care 25, 1-4, 2021 | 27 | 2021 |
| Diagnosis of idiopathic pulmonary fibrosis in high-resolution computed tomography scans using a combination of handcrafted radiomics and deep learning T Refaee, Z Salahuddin, AN Frix, C Yan, G Wu, HC Woodruff, H Gietema, ... Frontiers in medicine 9, 915243, 2022 | 25 | 2022 |
| Distinction of lymphoma from sarcoidosis on 18F-FDG PET/CT: evaluation of radiomics-feature–guided machine learning versus human reader performance P Lovinfosse, M Ferreira, N Withofs, A Jadoul, C Derwael, AN Frix, J Guiot, ... Journal of Nuclear Medicine 63 (12), 1933-1940, 2022 | 24 | 2022 |
| Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma AN Frix, F Schleich, V Paulus, F Guissard, M Henket, R Louis Biochemical Pharmacology 179, 113944, 2020 | 22 | 2020 |
| Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic J Guiot, M Henket, AN Frix, M Delvaux, A Denis, L Giltay, M Thys, F Gester, ... Respiratory investigation 58 (6), 437-439, 2020 | 20 | 2020 |
| Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study A Denis, M Henket, M Ernst, N Maes, M Thys, C Regnier, O Malaise, ... Frontiers in medicine 9, 1024298, 2022 | 13 | 2022 |
| Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study AN Frix, LG Heaney, B Dahlén, F Mihaltan, S Sergejeva, S Popović-Grle, ... ERJ open research 8 (4), 2022 | 13 | 2022 |
| Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial., 2022, 14, 3048 S De Niet, M Trémège, M Coffiner, AF Rousseau, D Calmes, AN Frix, ... DOI: https://doi. org/10.3390/nu14153048, 0 | 10 | |
| Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity J Guiot, N Maes, M Winandy, M Henket, B Ernst, M Thys, AN Frix, ... Frontiers in Medicine 9, 930055, 2022 | 9 | 2022 |
| Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype? J Guiot, M Henket, AN Frix, F Gester, M Thys, L Giltay, C Desir, ... Respiratory Research 23 (1), 89, 2022 | 8 | 2022 |
| Increased KL-6 levels in moderate to severe COVID-19 infection M Cambier, M Henket, AN Frix, S Gofflot, M Thys, S Tomasetti, A Peired, ... Plos one 17 (11), e0273107, 2022 | 6 | 2022 |
| COVID-19 et asthme. R Louis, D CALMES, AN Frix, F Schleich Revue Médicale de Liège 75 (S1), 2021 | 6 | 2021 |